Page last updated: 2024-10-17

chlorine and Arterial Occlusive Diseases

chlorine has been researched along with Arterial Occlusive Diseases in 16 studies

chloride : A halide anion formed when chlorine picks up an electron to form an an anion.

Arterial Occlusive Diseases: Pathological processes which result in the partial or complete obstruction of ARTERIES. They are characterized by greatly reduced or absence of blood flow through these vessels. They are also known as arterial insufficiency.

Research Excerpts

ExcerptRelevanceReference
"Human obesity is associated with an increased risk for arterial and venous thrombosis and with elevated levels of leptin in the blood."7.72Inhibition of endogenous leptin protects mice from arterial and venous thrombosis. ( Dellas, C; Konstantinides, S; Loskutoff, DJ; Neels, JG; Schäfer, K, 2004)
"Further to characterize the processes involved in the FeCl3-induced thrombosis model, we determined the effect of aspirin, heparin, hirudin, trans-4-(aminomethyl) cyclohexane carboxylic acid (AMCHA), thrombocytopenia, and flow modifications on time to occlusion (TTO) and thrombus weight (TW) in the rat carotid artery."7.70Demonstration of flow and platelet dependency in a ferric chloride-induced model of thrombosis. ( Kambayashi, J; Lockyer, S, 1999)
"Ferric chloride has been widely used to induce arterial thrombosis in a variety of species."5.33An optimized murine model of ferric chloride-induced arterial thrombosis for thrombosis research. ( Wang, X; Xu, L, 2005)
"To determine how CD73 activity influences in vivo thrombosis, the time to ferric chloride-induced arterial thrombosis was measured in CD73-null mice."3.83Role of the CD39/CD73 Purinergic Pathway in Modulating Arterial Thrombosis in Mice. ( Chepurko, E; Covarrubias, R; Cowan, PJ; Dwyer, KM; Gumina, RJ; Huttinger, R; Huttinger, ZM; Novitskaya, T; Reynolds, A; Robson, SC; Stanfill, K; Wheeler, DG, 2016)
" We hypothesized that anti-HSP60 autoantibodies could potentiate thrombosis, and evaluated the effect of anti-murine HSP60 antibodies in a ferric chloride (FeCl3)-induced murine model of carotid artery injury."3.75Autoantibodies to heat shock protein 60 promote thrombus formation in a murine model of arterial thrombosis. ( Dieudé, M; Gillis, MA; Lajoie, G; Levine, JS; Merhi, Y; Rauch, J; Théorêt, JF; Thorin, E, 2009)
"We used a model of carotid artery thrombosis induced by a ferric chloride injury to compare the time to first occlusion and occlusion rate at 25 min postinjury in mice lacking the collagen receptor, glycoprotein (GP) VI, or the ligand-binding domain of the VWF receptor, GP Ibalpha."3.73Distinct antithrombotic consequences of platelet glycoprotein Ibalpha and VI deficiency in a mouse model of arterial thrombosis. ( Almus-Jacobs, F; Konstantinides, S; Loskutoff, DJ; Marchese, P; Ruggeri, ZM; Ware, J, 2006)
"Human obesity is associated with an increased risk for arterial and venous thrombosis and with elevated levels of leptin in the blood."3.72Inhibition of endogenous leptin protects mice from arterial and venous thrombosis. ( Dellas, C; Konstantinides, S; Loskutoff, DJ; Neels, JG; Schäfer, K, 2004)
" In three different types of thrombosis models in rats, including stasis and thrombin-induced venous, glass surface-activated arterio-venous shunt, and ferric chloride-induced arterial thrombosis models, CX-397 and rHV-1 elicited potent antithrombotic effects, where the minimum effective doses of rHV-1 tended to be higher than those of CX-397 in the arterio-venous shunt and arterial thrombosis models."3.70Pharmacological effects of a novel recombinant hirudin, CX-397, in vivo and in vitro: comparison with recombinant hirudin variant-1, heparin, and argatroban. ( Fukazawa, T; Goto, Y; Hayashi, H; Inoue, Y; Komatsu, Y, 1999)
"Further to characterize the processes involved in the FeCl3-induced thrombosis model, we determined the effect of aspirin, heparin, hirudin, trans-4-(aminomethyl) cyclohexane carboxylic acid (AMCHA), thrombocytopenia, and flow modifications on time to occlusion (TTO) and thrombus weight (TW) in the rat carotid artery."3.70Demonstration of flow and platelet dependency in a ferric chloride-induced model of thrombosis. ( Kambayashi, J; Lockyer, S, 1999)
" In the dose-response study, a single administration of prasugrel at 0."1.42Prevention of occlusive arterial thrombus formation by a single loading dose of prasugrel suppresses neointimal hyperplasia in mice. ( Jakubowski, JA; Mizuno, M; Ohno, K; Sugidachi, A; Tomizawa, A, 2015)
"This study compared arterial to venous thrombosis in the mutationally analogous Factor V Leiden mouse."1.34Increased venous versus arterial thrombosis in the Factor V Leiden mouse. ( Chen, CY; Cooley, BC; Schmeling, G, 2007)
"However, neither its role in thrombus formation and cardiovascular disorders nor its suitability as a therapeutic target structure is entirely clear."1.34Diminished thrombus formation and alleviation of myocardial infarction and reperfusion injury through antibody- or small-molecule-mediated inhibition of selectin-dependent platelet functions. ( Boehncke, WH; Krahn, T; Ludwig, RJ; Nieswandt, B; Oostingh, GJ; Pozgajova, M; Schön, MP, 2007)
"Ferric chloride has been widely used to induce arterial thrombosis in a variety of species."1.33An optimized murine model of ferric chloride-induced arterial thrombosis for thrombosis research. ( Wang, X; Xu, L, 2005)

Research

Studies (16)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (18.75)18.2507
2000's7 (43.75)29.6817
2010's6 (37.50)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lu, DH1
Hsu, CC1
Huang, SW1
Tu, HJ1
Huang, TF1
Liou, HC1
Liao, HM1
Chen, CH1
Fu, WM1
Gau, SS1
Assumpção, TC1
Mizurini, DM1
Ma, D1
Monteiro, RQ1
Ahlstedt, S1
Reyes, M1
Kotsyfakis, M1
Mather, TN1
Andersen, JF1
Lukszo, J1
Ribeiro, JMC1
Francischetti, IMB1
Ohno, K1
Tomizawa, A1
Jakubowski, JA1
Mizuno, M1
Sugidachi, A1
Covarrubias, R1
Chepurko, E1
Reynolds, A1
Huttinger, ZM1
Huttinger, R1
Stanfill, K1
Wheeler, DG1
Novitskaya, T1
Robson, SC1
Dwyer, KM1
Cowan, PJ1
Gumina, RJ1
Dieudé, M1
Gillis, MA1
Théorêt, JF1
Thorin, E1
Lajoie, G1
Levine, JS1
Merhi, Y1
Rauch, J1
Baumgartner, B1
Jaki, T1
Wolfsegger, MJ1
Eder, B1
Schiviz, A1
Schwarz, HP1
Muchitsch, EM1
Korporaal, SJ1
Meurs, I1
Hauer, AD1
Hildebrand, RB1
Hoekstra, M1
Cate, HT1
Praticò, D1
Akkerman, JW1
Van Berkel, TJ1
Kuiper, J1
Van Eck, M1
Konstantinides, S2
Schäfer, K1
Neels, JG1
Dellas, C1
Loskutoff, DJ2
Wang, X1
Xu, L1
Matuskova, J1
Chauhan, AK1
Cambien, B1
Astrof, S1
Dole, VS1
Piffath, CL1
Hynes, RO1
Wagner, DD1
Cooley, BC1
Chen, CY1
Schmeling, G1
Ware, J1
Marchese, P1
Almus-Jacobs, F1
Ruggeri, ZM1
Oostingh, GJ1
Pozgajova, M1
Ludwig, RJ1
Krahn, T1
Boehncke, WH1
Nieswandt, B1
Schön, MP1
Nielsen, HT1
Olcott, EW1
Nishimura, DG1
Komatsu, Y1
Inoue, Y1
Goto, Y1
Fukazawa, T1
Hayashi, H1
Lockyer, S1
Kambayashi, J1

Other Studies

16 other studies available for chlorine and Arterial Occlusive Diseases

ArticleYear
ARHGEF10 knockout inhibits platelet aggregation and protects mice from thrombus formation.
    Journal of thrombosis and haemostasis : JTH, 2017, Volume: 15, Issue:10

    Topics: Animals; Arterial Occlusive Diseases; Blood Platelets; Carotid Artery Diseases; Cell Shape; Chloride

2017
Ixonnexin from Tick Saliva Promotes Fibrinolysis by Interacting with Plasminogen and Tissue-Type Plasminogen Activator, and Prevents Arterial Thrombosis.
    Scientific reports, 2018, 03-19, Volume: 8, Issue:1

    Topics: Animals; Arterial Occlusive Diseases; Chlorides; Ferric Compounds; Fibrinolysis; Mice; Noxae; Plasmi

2018
Prevention of occlusive arterial thrombus formation by a single loading dose of prasugrel suppresses neointimal hyperplasia in mice.
    Thrombosis research, 2015, Volume: 136, Issue:6

    Topics: Adenosine Diphosphate; Animals; Aorta; Arterial Occlusive Diseases; Arteries; Carotid Arteries; Chem

2015
Role of the CD39/CD73 Purinergic Pathway in Modulating Arterial Thrombosis in Mice.
    Arteriosclerosis, thrombosis, and vascular biology, 2016, Volume: 36, Issue:9

    Topics: 5'-Nucleotidase; Adenosine; Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate;

2016
Autoantibodies to heat shock protein 60 promote thrombus formation in a murine model of arterial thrombosis.
    Journal of thrombosis and haemostasis : JTH, 2009, Volume: 7, Issue:4

    Topics: Animals; Arterial Occlusive Diseases; Autoantibodies; Carotid Artery Diseases; Chaperonin 60; Chlori

2009
Optimization, refinement and reduction of murine in vivo experiments to assess therapeutic approaches for haemophilia A.
    Laboratory animals, 2010, Volume: 44, Issue:3

    Topics: Animal Use Alternatives; Animal Welfare; Animals; Arterial Occlusive Diseases; Carotid Artery Diseas

2010
Deletion of the high-density lipoprotein receptor scavenger receptor BI in mice modulates thrombosis susceptibility and indirectly affects platelet function by elevation of plasma free cholesterol.
    Arteriosclerosis, thrombosis, and vascular biology, 2011, Volume: 31, Issue:1

    Topics: Animals; Arterial Occlusive Diseases; Blood Platelets; Bone Marrow Transplantation; Chlorides; Chole

2011
Inhibition of endogenous leptin protects mice from arterial and venous thrombosis.
    Arteriosclerosis, thrombosis, and vascular biology, 2004, Volume: 24, Issue:11

    Topics: Animals; Antibodies, Blocking; Arterial Occlusive Diseases; Chlorides; Ferric Compounds; Leptin; Mic

2004
An optimized murine model of ferric chloride-induced arterial thrombosis for thrombosis research.
    Thrombosis research, 2005, Volume: 115, Issue:1-2

    Topics: Animals; Arterial Occlusive Diseases; Carotid Artery Diseases; Chlorides; Clopidogrel; Disease Model

2005
Decreased plasma fibronectin leads to delayed thrombus growth in injured arterioles.
    Arteriosclerosis, thrombosis, and vascular biology, 2006, Volume: 26, Issue:6

    Topics: Alternative Splicing; Animals; Arterial Occlusive Diseases; Arterioles; Bleeding Time; Blood Coagula

2006
Increased venous versus arterial thrombosis in the Factor V Leiden mouse.
    Thrombosis research, 2007, Volume: 119, Issue:6

    Topics: Amino Acid Substitution; Animals; Arginine; Arterial Occlusive Diseases; Arteries; Chlorides; Diseas

2007
Distinct antithrombotic consequences of platelet glycoprotein Ibalpha and VI deficiency in a mouse model of arterial thrombosis.
    Journal of thrombosis and haemostasis : JTH, 2006, Volume: 4, Issue:9

    Topics: Animals; Arterial Occlusive Diseases; Carotid Artery Thrombosis; Chlorides; Disease Models, Animal;

2006
Diminished thrombus formation and alleviation of myocardial infarction and reperfusion injury through antibody- or small-molecule-mediated inhibition of selectin-dependent platelet functions.
    Haematologica, 2007, Volume: 92, Issue:4

    Topics: Animals; Antibodies, Monoclonal; Arterial Occlusive Diseases; Chlorides; Drug Evaluation, Preclinica

2007
Improved 2D time-of-flight angiography using a radial-line k-space acquisition.
    Magnetic resonance in medicine, 1997, Volume: 37, Issue:2

    Topics: Arterial Occlusive Diseases; Artifacts; Blood Vessels; Chlorides; Humans; Image Enhancement; Image P

1997
Pharmacological effects of a novel recombinant hirudin, CX-397, in vivo and in vitro: comparison with recombinant hirudin variant-1, heparin, and argatroban.
    Thrombosis and haemostasis, 1999, Volume: 81, Issue:2

    Topics: Amino Acid Sequence; Animals; Arginine; Arterial Occlusive Diseases; Arteriovenous Shunt, Surgical;

1999
Demonstration of flow and platelet dependency in a ferric chloride-induced model of thrombosis.
    Journal of cardiovascular pharmacology, 1999, Volume: 33, Issue:5

    Topics: Animals; Antifibrinolytic Agents; Antithrombins; Arterial Occlusive Diseases; Aspirin; Blood Platele

1999